{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Denver&page=59&state=Colorado", "query": { "state": "Colorado", "city": "Denver", "page": 59 }, "page_size": 10 }, "pagination": { "page": 59, "page_size": 10, "total_count": 7459, "total_pages": 746, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Denver&page=60&state=Colorado&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Denver&page=58&state=Colorado&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T13:34:37.505Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00920868", "title": "XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor", "Metastatic Colorectal Cancer" ], "interventions": [ { "name": "dasatinib", "type": "DRUG" }, { "name": "bevacizumab", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Herbert Hurwitz, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2009-05", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2016-02-03", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 2, "location_summary": "Denver, Colorado • Durham, North Carolina", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920868" }, { "nct_id": "NCT00070174", "title": "Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "busulfan", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "gemtuzumab ozogamicin", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "mitoxantrone hydrochloride", "type": "DRUG" }, { "name": "allogeneic bone marrow transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 350, "start_date": "2003-12", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-02-20", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 134, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 111 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00070174" }, { "nct_id": "NCT01108510", "title": "Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV", "HIV Infections" ], "interventions": [ { "name": "COBI", "type": "DRUG" }, { "name": "RTV", "type": "DRUG" }, { "name": "ATV", "type": "DRUG" }, { "name": "FTC/TDF", "type": "DRUG" }, { "name": "COBI placebo", "type": "DRUG" }, { "name": "RTV placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 698, "start_date": "2010-04", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-05-23", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01108510" }, { "nct_id": "NCT03291717", "title": "Bridging Community Gaps Photovoice", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mental Illness", "Social Isolation" ], "interventions": [ { "name": "Bridging Community Gaps Photovoice (BCGP)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston University Charles River Campus", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 197, "start_date": "2017-09-05", "completion_date": "2020-09-11", "has_results": false, "last_update_posted_date": "2020-09-16", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 4, "location_summary": "Denver, Colorado • Bridgeport, Connecticut • Boston, Massachusetts + 1 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Wakefield", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03291717" }, { "nct_id": "NCT06177717", "title": "Deep Functional Phenotyping of the ALA Lung Health Cohort", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "25 Years to 35 Years" }, "enrollment_count": 1000, "start_date": "2024-02-12", "completion_date": "2027-03-30", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06177717" }, { "nct_id": "NCT02465450", "title": "Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "JBT-101 (lenabasum)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Corbus Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 85, "start_date": "2015-09-29", "completion_date": "2016-12-28", "has_results": true, "last_update_posted_date": "2018-04-04", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 12, "location_summary": "Little Rock, Arkansas • Long Beach, California • Denver, Colorado + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02465450" }, { "nct_id": "NCT02839850", "title": "14022 ATTUNE Cementless RP Clinical Performance Evaluation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis" ], "interventions": [ { "name": "Cementless Total Knee Arthroplasty", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "DePuy Orthopaedics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "22 Years to 80 Years" }, "enrollment_count": 540, "start_date": "2016-09-01", "completion_date": "2027-09-01", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 10, "location_summary": "Denver, Colorado • DeLand, Florida • Lebanon, New Hampshire + 7 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "DeLand", "state": "Florida" }, { "city": "Lebanon", "state": "New Hampshire" }, { "city": "New London", "state": "New Hampshire" }, { "city": "Egg Harbor", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02839850" }, { "nct_id": "NCT02971891", "title": "A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cutaneous Common Warts" ], "interventions": [ { "name": "CLS006 (Furosemide) Topical Gel", "type": "DRUG" }, { "name": "Vehicle Topical Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Maruho Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 484, "start_date": "2017-01", "completion_date": "2018-07-10", "has_results": true, "last_update_posted_date": "2023-09-14", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 30, "location_summary": "Mobile, Alabama • Glendale, Arizona • Los Angeles, California + 26 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02971891" }, { "nct_id": "NCT01818518", "title": "Neonatal Outcome by Reason for Delivery", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Preterm Delivery" ], "interventions": [], "intervention_types": [], "sponsor": "Obstetrix Medical Group", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 995, "start_date": "2013-07", "completion_date": "2016-07-25", "has_results": true, "last_update_posted_date": "2019-06-18", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 10, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 7 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Laguna Hills", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01818518" }, { "nct_id": "NCT00300885", "title": "A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Non-Small Cell Lung" ], "interventions": [ { "name": "Nexavar (Sorafenib, BAY43-9006) + carboplatin + paclitaxel", "type": "DRUG" }, { "name": "Carboplatin plus Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 926, "start_date": "2006-02", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2014-11-04", "last_synced_at": "2026-11-15T13:34:37.505Z", "location_count": 80, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00300885" } ] }